Although the exact mechanisms underlying these potentially beneficial effects remain to be fully elucidated, the suppressive effects of GM-CSF on COX-2 and iNOS expression in cancer cells appear to occur via a GM-CSFR-independent pathway, as suggested by the lack of GM-CSFR expression in cervical cancer cells. The gene discussed is CSF2; the disease is cervical carcinoma.